Home > Daniel A Vorobiof, ESMO 2018 – Prevalence of Cancer-related Fatigue
Supportive Cancer Care

Daniel A Vorobiof, ESMO 2018 – Prevalence of Cancer-related Fatigue

Published Online: November 15th 2018

Dr Daniel A Vorobiof, ​Chief Medical Officer at Belong.Life, New York, NY, US, provides an overview of the findings of his study on the impact of cancer-related fatigue on patients and caregivers, and options of management and prevention.​ Belong.Life is the world’s largest professional social network for cancer patients and caregivers.

1. Could you tell us a little about the design of your recent study on fatigue prevalence and adherence to treatment? (0:12)
2. How great a physical and emotional burden is cancer-related fatigue on patients and their caregivers? (1:09)
3. What was the impact of fatigue on treatment adherence? (1.56)
4. How can patients and caregivers prevent and manage fatigue associated with cancer therapy? (3:10)
5. What are the key messages of this study in terms of unmet needs of patient care? (4:04)

Speaker disclosures: Daniel A Vorobiof has nothing to disclose in relation to this video interview.

Filmed at the European Society for Medical Oncology (ESMO) 2018 Congress, Munich, Germany, 19–23 October 2018.

Related Videos In Supportive Cancer Care
  • Copied to clipboard!
    accredited arrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greyarrow-right-orangearrow-right-whitearrow-right-blueavatarcalendarchevron-down crosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmenumore_dots padlock person play_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-whiteticktimetranscriptup-arrowwebinar